Amneal Pharmaceuticals, Inc. (AMRX): Price and Financial Metrics


Amneal Pharmaceuticals, Inc. (AMRX)

Today's Latest Price: $4.21 USD

0.11 (2.68%)

Updated Dec 4 4:00pm

Add AMRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AMRX Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for AMRX is 6.24 -- better than 94.43% of US stocks.
  • AMRX's went public 2.69 years ago, making it older than just 7.97% of listed US stocks we're tracking.
  • AMRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 96.4% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Amneal Pharmaceuticals Inc are ALSN, ITGR, CAE, ENVA, and CC.
  • Visit AMRX's SEC page to see the company's official filings. To visit the company's web site, go to www.amneal.com.

AMRX Stock Price Chart Interactive Chart >

Price chart for AMRX

AMRX Price/Volume Stats

Current price $4.21 52-week high $5.79
Prev. close $4.10 52-week low $2.40
Day low $4.07 Volume 748,378
Day high $4.26 Avg. volume 1,539,762
50-day MA $4.40 Dividend yield N/A
200-day MA $4.16 Market Cap 1.26B

Amneal Pharmaceuticals, Inc. (AMRX) Company Bio


Amneal Pharmaceuticals (formerly Impax Laboratories) develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. The company was founded in 1993 and is based in Hayward, California.

AMRX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$4.21$34.72 759%

Below please find a table outlining a discounted cash flow forecast for AMRX, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amneal Pharmaceuticals Inc ranked in the 84th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 763.67% on a DCF basis. As for the metrics that stood out in our discounted cash flow analysis of Amneal Pharmaceuticals Inc, consider:

  • 17% of the company's capital comes from equity, which is greater than only 5.09% of stocks in our cash flow based forecasting set.
  • Amneal Pharmaceuticals Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
  • Relative to other stocks in its sector (Healthcare), Amneal Pharmaceuticals Inc has a reliance on debt greater than 95.75% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%743%
1%751%
2%759%
3%768%
4%776%
5%785%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as AMRX, try PRSC, ARGX, GTS, HCA, and NHC.


AMRX Latest News Stream


Event/Time News Detail
Loading, please wait...

AMRX Latest Social Stream


Loading social stream, please wait...

View Full AMRX Social Stream

Latest AMRX News From Around the Web

Below are the latest news stories about Amneal Pharmaceuticals Inc that investors may wish to consider to help them evaluate AMRX as an investment opportunity.

Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

Amneal Pharmaceuticals (AMRX) Gains As Market Dips: What You Should Know

In the latest trading session, Amneal Pharmaceuticals (AMRX) closed at $4.46, marking a +0.45% move from the previous day.

Yahoo | July 23, 2020

Can Amneal (AMRX) Keep the Earnings Surprise Streak Alive?

Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | July 22, 2020

Amneal Pharmaceuticals (AMRX) Gains But Lags Market: What You Should Know

Amneal Pharmaceuticals (AMRX) closed the most recent trading day at $4.86, moving +0.21% from the previous trading session.

Yahoo | July 17, 2020

Could The Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Ownership Structure Tell Us Something Useful?

The big shareholder groups in Amneal Pharmaceuticals, Inc. (NYSE:AMRX) have power over the company. Insiders often own...

Yahoo | July 16, 2020

Read More 'AMRX' Stories Here

AMRX Price Returns

1-mo -12.29%
3-mo 15.34%
6-mo -14.95%
1-year 13.48%
3-year -74.64%
5-year -90.48%
YTD -12.66%
2019 -64.38%
2018 -18.74%
2017 25.66%
2016 -69.01%
2015 34.97%

Continue Researching AMRX

Here are a few links from around the web to help you further your research on Amneal Pharmaceuticals Inc's stock as an investment opportunity:

Amneal Pharmaceuticals Inc (AMRX) Stock Price | Nasdaq
Amneal Pharmaceuticals Inc (AMRX) Stock Quote, History and News - Yahoo Finance
Amneal Pharmaceuticals Inc (AMRX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8409 seconds.